Small cap biopharma, undervalued
Puma biotech buys licenses for oncology treatments that have gone through testing, and brings them to market. I will hold until the ticker hits my target range (7-8 USD,) reevaluate (using FA and TA, and current market conditions to determine price channel and optimize execution,) and trade out.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
It’s a beautiful day!
Former scientist, enthusiastic reader and student of capital markets. LT/s-trade/options/crypto
134Followers
163Following
621Visitors
Follow